Big Insurers Try to Shift Blame for High Health Costs to Hospitals and Drug Makers
At two congressional hearings, lawmakers slammed executives of major companies, [...]
Trump Outlines Health Care Proposals as Prices and Premiums Rise
The long-awaited plan would leave much to Congress and calls [...]
How Cameroon Fought to Save Its Malaria Program After the U.S. Cut Critical Funding
When the Trump administration slashed foreign aid, it gutted a [...]
Trump Announces Pricing Deals With Nine Drugmakers
The companies were the latest to agree to sell drugs [...]
F.D.A. Turmoil Keeps Spotlight on Its Commissioner
The agency’s high-level turnover and conflicting policy decisions on drug [...]
President Trump Reclassifies Marijuana With Executive Order
Marijuana was downgraded from a Schedule I drug to a [...]
To Avoid Pharma Tariffs, U.K. Agrees to Trump’s Demand to Pay More for Drugs
President Trump has complained that wealthy countries like Britain pay [...]
Extreme Measures for the Fentanyl Crisis
Readers respond to a guest essay about America’s fentanyl problem. [...]
U.S. Announces Negotiated Prices for 15 Drugs Under Medicare
The Trump administration said that had the new prices been [...]
Eli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Value
The 150-year-old drugmaker is the first company in health care [...]